| Names | |
|---|---|
| Systematic IUPAC name 1-(Benzo[d][1,3]dioxol-5-yl)-2-(dimethylamino)butan-1-one | |
| Other names 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one; β-Keto-dimethylbenzodioxolylbutanamine; bk-DMBDB | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChemSpider | |
| UNII |
|
| |
| |
| Properties | |
| C13H17NO3 | |
| Molar mass | 235.283 g·mol−1 |
| Pharmacology | |
| Legal status |
|
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Dibutylone (bk-DMBDB[2]) is astimulant drug of theamphetamine,phenethylamine,cathinone, andphenylisobutylamine families. It is structurally related tobutylone, adesigner drug that has been detected in products marketed asbath salts or plant food.[3]
In 2018, dibutylone was the third most common drug of the cathinone class to be identified inDrug Enforcement Administration seizures.[4]
In United States, dibutylone is on the list ofSchedule I Controlled Substances as a positional isomer ofpentylone.[5]